Heron Therapeutics Inc (HRTX)
2.65
-0.15
(-5.36%)
USD |
NASDAQ |
Apr 24, 16:00
2.67
+0.02
(+0.75%)
After-Hours: 20:00
Heron Therapeutics Cash and Short Term Investments (Quarterly): 80.41M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 80.41M |
September 30, 2023 | 77.41M |
June 30, 2023 | 33.24M |
March 31, 2023 | 60.02M |
December 31, 2022 | 84.85M |
September 30, 2022 | 121.75M |
June 30, 2022 | 83.54M |
March 31, 2022 | 111.91M |
December 31, 2021 | 157.58M |
September 30, 2021 | 202.82M |
June 30, 2021 | 257.68M |
March 31, 2021 | 166.47M |
December 31, 2020 | 208.49M |
September 30, 2020 | 258.15M |
June 30, 2020 | 300.84M |
March 31, 2020 | 356.35M |
December 31, 2019 | 390.97M |
September 30, 2019 | 256.28M |
June 30, 2019 | 276.00M |
March 31, 2019 | 289.24M |
December 31, 2018 | 332.37M |
September 30, 2018 | 364.80M |
June 30, 2018 | 422.96M |
March 31, 2018 | 113.94M |
December 31, 2017 | 172.38M |
Date | Value |
---|---|
September 30, 2017 | 74.02M |
June 30, 2017 | 109.26M |
March 31, 2017 | 165.22M |
December 31, 2016 | 51.14M |
September 30, 2016 | 88.92M |
June 30, 2016 | 74.64M |
March 31, 2016 | 100.41M |
December 31, 2015 | 131.17M |
September 30, 2015 | 152.99M |
June 30, 2015 | 171.53M |
March 31, 2015 | 55.56M |
December 31, 2014 | 72.68M |
September 30, 2014 | 86.21M |
June 30, 2014 | 105.01M |
March 31, 2014 | 57.48M |
December 31, 2013 | 72.29M |
September 30, 2013 | 22.60M |
June 30, 2013 | 34.85M |
March 31, 2013 | 45.72M |
December 31, 2012 | 53.51M |
September 30, 2012 | 60.05M |
June 30, 2012 | 12.44M |
March 31, 2012 | 13.44M |
December 31, 2011 | 17.97M |
September 30, 2011 | 21.02M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
33.24M
Minimum
Jun 2023
390.97M
Maximum
Dec 2019
183.41M
Average
166.47M
Median
Mar 2021
Cash and Short Term Investments (Quarterly) Benchmarks
United Therapeutics Corp | 2.994B |
Esperion Therapeutics Inc | 82.25M |
Aldeyra Therapeutics Inc | 142.82M |
Ocular Therapeutix Inc | 195.81M |
Clearside Biomedical Inc | 28.92M |